Emily Blair Larkin, MD | |
608 Cheat Rd, Morgantown, WV 26508-4210 | |
(304) 594-1313 | |
(304) 594-2408 |
Full Name | Emily Blair Larkin |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 11 Years |
Location | 608 Cheat Rd, Morgantown, West Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073956389 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 26373 (West Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
West Virginia University Hospitals | Morgantown, WV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
West Virginia University Medical Corporation | 1052224565 | 1613 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration. CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).
A defect in the mechanics of motors that build tiny cellular hairs is the basis of a serious genetic disorder, according to researchers at UC Davis and Simon Fraser University, Canada.
The head of the nation's biggest hospital yesterday explained how the UAE can overcome the worldwide shortage of medical staff, days after a report revealed that the number of doctors and nurses will have to double within a decade.
LigoCyte Pharmaceuticals, Inc. announced today that it has initiated its third human clinical trial of its norovirus vaccine. The Phase I/II study will assess safety and immunogenicity associated with LigoCyte's investigational, nasally-delivered, dry powder vaccine in healthy adults. The study will also assess potential protection against clinical symptoms of norovirus infection by including a live virus challenge of subjects that have received either the vaccine or placebo.
› Verified 9 days ago
Entity Name | West Virginia University Medical Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration. CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).
A defect in the mechanics of motors that build tiny cellular hairs is the basis of a serious genetic disorder, according to researchers at UC Davis and Simon Fraser University, Canada.
The head of the nation's biggest hospital yesterday explained how the UAE can overcome the worldwide shortage of medical staff, days after a report revealed that the number of doctors and nurses will have to double within a decade.
LigoCyte Pharmaceuticals, Inc. announced today that it has initiated its third human clinical trial of its norovirus vaccine. The Phase I/II study will assess safety and immunogenicity associated with LigoCyte's investigational, nasally-delivered, dry powder vaccine in healthy adults. The study will also assess potential protection against clinical symptoms of norovirus infection by including a live virus challenge of subjects that have received either the vaccine or placebo.
› Verified 9 days ago
Entity Name | West Virginia University Hospitals Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598847634 PECOS PAC ID: 9537077441 Enrollment ID: O20050404000512 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration. CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).
A defect in the mechanics of motors that build tiny cellular hairs is the basis of a serious genetic disorder, according to researchers at UC Davis and Simon Fraser University, Canada.
The head of the nation's biggest hospital yesterday explained how the UAE can overcome the worldwide shortage of medical staff, days after a report revealed that the number of doctors and nurses will have to double within a decade.
LigoCyte Pharmaceuticals, Inc. announced today that it has initiated its third human clinical trial of its norovirus vaccine. The Phase I/II study will assess safety and immunogenicity associated with LigoCyte's investigational, nasally-delivered, dry powder vaccine in healthy adults. The study will also assess potential protection against clinical symptoms of norovirus infection by including a live virus challenge of subjects that have received either the vaccine or placebo.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Emily Blair Larkin, MD 608 Cheat Rd, Morgantown, WV 26508-4210 Ph: (304) 594-1313 | Emily Blair Larkin, MD 608 Cheat Rd, Morgantown, WV 26508-4210 Ph: (304) 594-1313 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration. CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).
A defect in the mechanics of motors that build tiny cellular hairs is the basis of a serious genetic disorder, according to researchers at UC Davis and Simon Fraser University, Canada.
The head of the nation's biggest hospital yesterday explained how the UAE can overcome the worldwide shortage of medical staff, days after a report revealed that the number of doctors and nurses will have to double within a decade.
LigoCyte Pharmaceuticals, Inc. announced today that it has initiated its third human clinical trial of its norovirus vaccine. The Phase I/II study will assess safety and immunogenicity associated with LigoCyte's investigational, nasally-delivered, dry powder vaccine in healthy adults. The study will also assess potential protection against clinical symptoms of norovirus infection by including a live virus challenge of subjects that have received either the vaccine or placebo.
› Verified 9 days ago
Dr. James B Mersing, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mon Health Medical Park Dr Ste 1201, Morgantown, WV 26505 Phone: 304-599-9400 Fax: 304-599-8917 | |
Robert John Bowers Ii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3910 Westlake Dr, 101, Morgantown, WV 26508 Phone: 304-594-9209 Fax: 304-599-8917 | |
Dr. Dorian J Williams, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-598-6900 Fax: 304-293-6963 | |
Mrs. Holly Beth Hartman-adams, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-598-6900 | |
Troy Lynn Sedlmeyer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Fairmont Rd, Morgantown, WV 26501 Phone: 304-292-7316 Fax: 304-296-4408 | |
Karim Ibrahim, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6000 Memorial Church Dr Ste A, Morgantown, WV 26501 Phone: 304-598-7313 Fax: 304-598-7319 | |
Elizabeth Kane, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 930 Chestnut Ridge Rd, Morgantown, WV 26505 Phone: 304-598-4214 |